Lifeward Ltd. - Ordinary Shares (NQ:LFWD)

7.220 +0.220 (+3.14%)

Streaming Delayed Price Updated: 3:52 PM EDT, Jul 31, 2026 Add to My Watchlist

Price and Volume

Volume	1,610
Open	6.940
Bid (Size)	6.880 (100)
Ask (Size)	7.500 (100)
Prev. Close	7.000
Today's Range	6.940 - 7.220
52wk Range	4.140 - 10.56
Shares Outstanding	62,509,872
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Lifeward Secures Growth Capital to Accelerate Commercial Expansion with Up to $11.2 Million in Strategic Financing

July 07, 2026

Initial $5.6 million provides immediate capital to accelerate commercialization of Lifeward's restorative healthcare platform; additional $5.6 million available upon achievement of defined commercial...

From Lifeward Ltd.

Via GlobeNewswire

Lifeward (LFWD) Q4 2025 Earnings Transcript ↗

May 21, 2026

Lifeward (LFWD) Q4 2025 Earnings Transcript

Via The Motley Fool

Performance

YTD	-3.5%	-3.5%
1 Month	-6.1%	-6.1%
3 Month	-0.3%	-0.3%
6 Month	-0.6%	-0.6%
1 Year	-14.5%	-14.5%

More News

Lifeward Appoints Dr. Keith D. Rose as Chief Medical Officer to Support Expansion of Neurorehabilitation Portfolio and Advance Biomed Platform

May 19, 2026

From Lifeward Ltd.

Via GlobeNewswire

Lifeward Ltd (NASDAQ:LFWD) Q1 Revenue Misses Estimates as Strategic Transformation Takes Shape ↗

May 15, 2026

Via Chartmill

Lifeward (LFWD) Q1 2026 Earnings Transcript ↗

May 15, 2026

Via The Motley Fool

Lifeward Reports First Quarter 2026 Financial Results

May 15, 2026

From Lifeward Ltd.

Via GlobeNewswire

Lifeward to Report First Quarter 2026 Financial Results on May 15, 2026

May 11, 2026

From Lifeward Ltd.

Via GlobeNewswire

Lifeward Announces New ReWalk® Data Presented at ASIA 2026 Conference Demonstrating a Comprehensive Longitudinal Safety Analysis for a Powered Exoskeleton

May 04, 2026

From Lifeward Ltd.

Via GlobeNewswire

Lifeward Successfully Closes on Strategic Partnership with Oramed

March 25, 2026

From Lifeward Ltd.

Via GlobeNewswire

Lifeward Reports Fourth Quarter and Full Year 2025 Financial Results

March 18, 2026

From Lifeward Ltd.

Via GlobeNewswire

Lifeward Receives Shareholder Approval to Close on Strategic Partnership with Oramed—Creating Diversified Biomedical Company

March 13, 2026

From Lifeward Ltd.

Via GlobeNewswire

Lifeward Regains Compliance with Nasdaq Minimum Bid Price Requirement

March 11, 2026

From Lifeward Ltd.

Via GlobeNewswire

Lifeward to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026

March 10, 2026

From Lifeward Ltd.

Via GlobeNewswire

Lifeward Announces Collaboration With Shirley Ryan AbilityLab to Expand Access for the ReWalk Personal Exoskeleton

March 02, 2026

From Lifeward Ltd.

Via GlobeNewswire

Lifeward to Acquire Powered Upper Body Exoskeleton with AI Capabilities Designed to Restore Function to Stroke Survivors

February 25, 2026

From Lifeward Ltd.

Via GlobeNewswire

LFWD Stock Sinks To Record Low On Second Reverse Split In Two Years ↗

February 20, 2026

Via Stocktwits

Lifeward Announces Reverse Share Split

February 20, 2026

From Lifeward Ltd.

Via GlobeNewswire

Lifeward’s ReWalk™ Personal Exoskeleton Now Covered by Aetna, Coverage Expands to Include Three of the Largest Medicare Advantage Insurers

February 17, 2026

From Lifeward Ltd.

Via GlobeNewswire

Lifeward Enters Transformative Strategic Investment and Partnership Agreement with Oramed to Create a Diversified Biomedical Innovation Company

January 13, 2026

From Lifeward Ltd.

Via GlobeNewswire

Lifeward Appoints Bob Marshall as Chairman of the Board

December 19, 2025

From Lifeward Ltd.

Via GlobeNewswire

Lifeward Expands International Distribution of its ReWalk® Personal Robotic Exoskeleton into Mexico, Thailand, and the United Arab Emirates

December 17, 2025

From Lifeward Ltd.

Via GlobeNewswire

Stay updated with the stocks that are on the move in today's after-hours session. ↗

December 03, 2025

Via Chartmill

Lifeward Broadens Reimbursement Coverage for ReWalk 7 Personal Robotic Exoskeleton as Humana Medicare Advantage Plan Issues Prior Authorization Approval

December 03, 2025

From Lifeward Ltd.

Via GlobeNewswire

UnitedHealthcare Medicare Advantage Plan Issues Prior Authorization Approval for a ReWalk 7 Personal Exoskeleton

November 17, 2025

From Lifeward Ltd.

Via GlobeNewswire

Lifeward Ltd (NASDAQ:LFWD) Reports Mixed Q3 2025 Results ↗

November 14, 2025

Via Chartmill

Frequently Asked Questions

Is Lifeward Ltd. - Ordinary Shares publicly traded?

Yes, Lifeward Ltd. - Ordinary Shares is publicly traded.

What exchange does Lifeward Ltd. - Ordinary Shares trade on?

Lifeward Ltd. - Ordinary Shares trades on the Nasdaq Stock Market

What is the ticker symbol for Lifeward Ltd. - Ordinary Shares?

The ticker symbol for Lifeward Ltd. - Ordinary Shares is LFWD on the Nasdaq Stock Market

What is the current price of Lifeward Ltd. - Ordinary Shares?

The current price of Lifeward Ltd. - Ordinary Shares is 7.220

When was Lifeward Ltd. - Ordinary Shares last traded?

The last trade of Lifeward Ltd. - Ordinary Shares was at 07/31/26 03:52 PM ET

What is the market capitalization of Lifeward Ltd. - Ordinary Shares?

The market capitalization of Lifeward Ltd. - Ordinary Shares is 451.32M

How many shares of Lifeward Ltd. - Ordinary Shares are outstanding?

Lifeward Ltd. - Ordinary Shares has 451M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.